ES2136557B1 - Producto para tratamiento de la queratitis seca. - Google Patents

Producto para tratamiento de la queratitis seca.

Info

Publication number
ES2136557B1
ES2136557B1 ES9701833A ES9701833A ES2136557B1 ES 2136557 B1 ES2136557 B1 ES 2136557B1 ES 9701833 A ES9701833 A ES 9701833A ES 9701833 A ES9701833 A ES 9701833A ES 2136557 B1 ES2136557 B1 ES 2136557B1
Authority
ES
Spain
Prior art keywords
treatment
product
dry keratitis
keratitis
dry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9701833A
Other languages
English (en)
Other versions
ES2136557A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES9701833A priority Critical patent/ES2136557B1/es
Publication of ES2136557A1 publication Critical patent/ES2136557A1/es
Application granted granted Critical
Publication of ES2136557B1 publication Critical patent/ES2136557B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Producto para el tratamiento de la queratitis seca. Se tratade una solución de glutation al 100% en forma de colirio, para el tratamiento de la queratitis seca disuelta en 3 ml. de agua estéril y participación de suero bicarbonatado para normalización del PH.
ES9701833A 1997-08-22 1997-08-22 Producto para tratamiento de la queratitis seca. Expired - Fee Related ES2136557B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9701833A ES2136557B1 (es) 1997-08-22 1997-08-22 Producto para tratamiento de la queratitis seca.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9701833A ES2136557B1 (es) 1997-08-22 1997-08-22 Producto para tratamiento de la queratitis seca.

Publications (2)

Publication Number Publication Date
ES2136557A1 ES2136557A1 (es) 1999-11-16
ES2136557B1 true ES2136557B1 (es) 2000-07-01

Family

ID=8300452

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9701833A Expired - Fee Related ES2136557B1 (es) 1997-08-22 1997-08-22 Producto para tratamiento de la queratitis seca.

Country Status (1)

Country Link
ES (1) ES2136557B1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443432A (en) * 1981-10-05 1984-04-17 Alcon Laboratories, Inc. Ophthmalic irrigating solution
US4837021A (en) * 1986-12-31 1989-06-06 Laboratoires P.O.S. Two part tissue irrigating solution
JPH0611704B2 (ja) * 1989-01-19 1994-02-16 参天製薬株式会社 角膜疾患治療用点眼剤
US5596011A (en) * 1995-04-06 1997-01-21 Repine; Karen M. Method for the treatment of macular degeneration

Also Published As

Publication number Publication date
ES2136557A1 (es) 1999-11-16

Similar Documents

Publication Publication Date Title
USD471748S1 (en) Tissue holder
BR9910251A (pt) Estimulação hematopoiética
FR2784294B1 (fr) Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d'acide salicylique
BR0009964A (pt) Peptìdios artificiais com atividade desuperfìcie e sua utilização na preparação de surfactante artificial
SE9503143D0 (sv) New preparation
ATE386506T1 (de) Verabreichung unlöslicher arzneistoffe
ES2165429T3 (es) Solucion salada para tratar las lentes de contacto.
DK1143967T3 (da) Anticonvulsive derivater egnede til behandling af Hortons hovedpine
TR200200716T2 (tr) Ketiyapin granülleri
BR0012568A (pt) Inibidores do transporte de fosfato
USD404551S (en) Shoe bottom
CA2309172A1 (en) Aminobiguanides to disinfect contact lenses and preserve pharmaceutical compositions
IE900073L (en) Treatment of diseases associated with hiv infections
CA2250379A1 (en) Water treatment composition
DE69625200D1 (de) Arzneimittel enthaltend lamotrigin
TW337997B (en) Pharmaceutical preparation containing plasminogen activators
WO2000000214A3 (en) Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms
SE9801090L (sv) Odlingsmedium för animalceller
BR9912166A (pt) Uso de dióxido de carbono e ácido carbÈnico para limpeza de lentes de contato
ES2145054T3 (es) Un reactivo estabilizado por sales de metal bivalente.
BG104825A (en) Ophthalmic solution comprising glycogen
ES2178200T3 (es) Conservante para lentes de contacto, solido y soluble en agua.
USD490875S1 (en) Water treating device
TNSN04055A1 (fr) Formes cristallines anhydres de gabapentine
ES2070806B1 (es) Jarabe que contiene n-acetil-cisteina.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19991116

Kind code of ref document: A1

Effective date: 19991116

FD1A Patent lapsed

Effective date: 20050823